Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

27.69
-0.4000-1.42%
Volume:1.71M
Turnover:47.07M
Market Cap:3.11B
PE:-27.46
High:28.30
Open:28.18
Low:26.97
Close:28.09
Loading ...
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2024

Proposed Sale Of Securities

Form144 | Viking Therapeutics' Officer Greg Zante proposes to sell 16,136 shares, with a total value of approximately $922,232.10.
Jul 30, 2024

Proposed Sale Of Securities

Form144 | Viking Therapeutics' Officer Brian Lian proposes to sell 115,859 shares, with a total value of approximately $6.67 Million.
Jul 30, 2024

Proposed Sale Of Securities

Form144 | Viking Therapeutics' Officer Marianna Mancini proposes to sell 18,026 shares, with a total value of approximately $1.03 million.
Jul 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments